NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr | ₹163 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹147 Cr |
Mar2022 | ₹180 Cr |
Mar2021 | ₹170 Cr |
Mar2020 | ₹163 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | -16.73 | |
Mar2023 | ₹147 Cr | -18.42 | |
Mar2022 | ₹180 Cr | 5.90 | |
Mar2021 | ₹170 Cr | 3.94 | |
Mar2020 | ₹163 Cr | - |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹14,218.5 Cr | -8.1% | -18.7% | 84.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
CIPLA | ₹118,041.0 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -8.1% |
-18.7% |
84.7% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses